The Prostate

Cover image for The Prostate

15 September 2008

Volume 68, Issue 13

Pages 1373–1486

  1. Original Articles

    1. Top of page
    2. Original Articles
    1. Sequence variants of α-methylacyl-CoA racemase are associated with prostate cancer risk: A replication study in an ethnically homogeneous population (pages 1373–1379)

      Liesel M. FitzGerald, Russell Thomson, Andrea Polanowski, Briony Patterson, James D. McKay, James Stankovich and Joanne L. Dickinson

      Version of Record online: 6 JUN 2008 | DOI: 10.1002/pros.20798

    2. Pathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: Implications for unilateral ablative therapy (pages 1380–1386)

      Thomas J. Polascik, Janice M. Mayes, Leon Sun, John F. Madden, Judd W. Moul and Vladimir Mouraviev

      Version of Record online: 9 JUN 2008 | DOI: 10.1002/pros.20804

    3. GOLPH2 and MYO6: Putative prostate cancer markers localized to the Golgi apparatus (pages 1387–1395)

      Shuanzeng Wei, Thomas A. Dunn, William B. Isaacs, Angelo M. De Marzo and Jun Luo

      Version of Record online: 9 JUN 2008 | DOI: 10.1002/pros.20806

    4. Dickkopf-1 expression increases early in prostate cancer development and decreases during progression from primary tumor to metastasis (pages 1396–1404)

      Christopher L. Hall, Stephanie D. Daignault, Rajal B. Shah, Kenneth J. Pienta and Evan T. Keller

      Version of Record online: 16 JUN 2008 | DOI: 10.1002/pros.20805

    5. No association between a polymorphic variant of the IRS-1 gene and prostate cancer risk (pages 1416–1420)

      K. Fall, J.R. Stark, L.A. Mucci, J. Chan, M.J. Stampfer, T. Kurth, P.G. Febbo, P. Kantoff and J. Ma

      Version of Record online: 9 JUL 2008 | DOI: 10.1002/pros.20797

    6. Androgen regulation of multidrug resistance-associated protein 4 (MRP4/ABCC4) in prostate cancer (pages 1421–1429)

      Lye Lin Ho, James G. Kench, David J. Handelsman, George L. Scheffer, Phillip D. Stricker, John G. Grygiel, Robert L. Sutherland, Susan M. Henshall, John D. Allen and Lisa G. Horvath

      Version of Record online: 9 JUL 2008 | DOI: 10.1002/pros.20809

    7. T40214/PEI complex: A potent therapeutics for prostate cancer that targets STAT3 signaling (pages 1430–1442)

      Priya Weerasinghe, Yifei Li, Yongli Guan, Ruiwen Zhang, David J. Tweardy and Naijie Jing

      Version of Record online: 9 JUL 2008 | DOI: 10.1002/pros.20807

    8. Depletion of intracellular zinc increases expression of tumorigenic cytokines VEGF, IL-6 and IL-8 in prostate cancer cells via NF-κB-dependent pathway (pages 1443–1449)

      Konstantin Golovine, Robert G. Uzzo, Peter Makhov, Paul L. Crispen, David Kunkle and Vladimir M. Kolenko

      Version of Record online: 9 JUL 2008 | DOI: 10.1002/pros.20810

    9. Androgen-dependent activation of human cytomegalovirus major immediate-early promoter in prostate cancer cells (pages 1450–1460)

      Jong-Seok Moon, Min-Young Lee, Sahng Wook Park, Woong Kyu Han, Soon-Won Hong, Jin-Hyun Ahn and Kyung-Sup Kim

      Version of Record online: 9 JUL 2008 | DOI: 10.1002/pros.20817

    10. Phase II study of fulvestrant (faslodex®) in castration resistant prostate cancer (pages 1461–1466)

      Manpreet K. Chadha, Umeer Ashraf, David Lawrence, Lili Tian, Ellis Levine, Carrie Silliman, Paul Escott, Valencia Payne and Donald L. Trump

      Version of Record online: 10 JUL 2008 | DOI: 10.1002/pros.20813

    11. The ratio of matrix metalloproteinase to E-cadherin expression: A pilot study to assess mRNA and protein expression among African American prostate cancer patients (pages 1467–1476)

      Curtis A. Pettaway, Renduo Song, Xuemei Wang, Ricardo Sanchez-Ortiz, Philippe E. Spiess, Sara Strom and Patricia Troncoso

      Version of Record online: 10 JUL 2008 | DOI: 10.1002/pros.20812

    12. Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial (pages 1477–1486)

      Marian L. Neuhouser, Jeannette Schenk, Yoon Ju Song, Catherine M. Tangen, Phyllis J. Goodman, Michael Pollak, David F. Penson, Ian M. Thompson and Alan R. Kristal

      Version of Record online: 10 JUL 2008 | DOI: 10.1002/pros.20819